BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 33372898)

  • 1. Targeting mitophagy in Parkinson's disease.
    Clark EH; Vázquez de la Torre A; Hoshikawa T; Briston T
    J Biol Chem; 2021; 296():100209. PubMed ID: 33372898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic approaches to enhance PINK1/Parkin mediated mitophagy for the treatment of Parkinson's disease.
    Miller S; Muqit MMK
    Neurosci Lett; 2019 Jul; 705():7-13. PubMed ID: 30995519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
    Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
    Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Michael J. Fox Foundation for Parkinson's Research Strategy to Advance Therapeutic Development of PINK1 and Parkin.
    Padmanabhan S; Polinski NK; Menalled LB; Baptista MAS; Fiske BK
    Biomolecules; 2019 Jul; 9(8):. PubMed ID: 31344817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkinson's disease-associated VPS35 mutant reduces mitochondrial membrane potential and impairs PINK1/Parkin-mediated mitophagy.
    Ma KY; Fokkens MR; Reggiori F; Mari M; Verbeek DS
    Transl Neurodegener; 2021 Jun; 10(1):19. PubMed ID: 34127073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-degron-mediated degradation and regulation of mitochondrial PINK1 kinase.
    Eldeeb MA; Ragheb MA
    Curr Genet; 2020 Aug; 66(4):693-701. PubMed ID: 32157382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?
    Truban D; Hou X; Caulfield TR; Fiesel FC; Springer W
    J Parkinsons Dis; 2017; 7(1):13-29. PubMed ID: 27911343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitophagy in Parkinson's Disease: From Pathogenesis to Treatment.
    Liu J; Liu W; Li R; Yang H
    Cells; 2019 Jul; 8(7):. PubMed ID: 31336937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitophagy: the latest problem for Parkinson's disease.
    Vives-Bauza C; Przedborski S
    Trends Mol Med; 2011 Mar; 17(3):158-65. PubMed ID: 21146459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-content phenotypic screen to identify small molecule enhancers of Parkin-dependent ubiquitination and mitophagy.
    Tufi R; Clark EH; Hoshikawa T; Tsagkaraki C; Stanley J; Takeda K; Staddon JM; Briston T
    SLAS Discov; 2023 Apr; 28(3):73-87. PubMed ID: 36608804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by mitophagy.
    Hattori N; Saiki S; Imai Y
    Int J Biochem Cell Biol; 2014 Aug; 53():147-50. PubMed ID: 24842103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of PTEN-L in Modulating PINK1-Parkin-Mediated Mitophagy.
    Eldeeb MA; Esmaili M; Hassan M; Ragheb MA
    Neurotox Res; 2022 Aug; 40(4):1103-1114. PubMed ID: 35699891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide induction of Parkin translocation in PTEN-induced putative kinase 1 (PINK1) deficiency: functional role of neuronal nitric oxide synthase during mitophagy.
    Han JY; Kang MJ; Kim KH; Han PL; Kim HS; Ha JY; Son JH
    J Biol Chem; 2015 Apr; 290(16):10325-35. PubMed ID: 25716315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Huang Lian Jie Du Tang attenuates paraquat-induced mitophagy in human SH-SY5Y cells: A traditional decoction with a novel therapeutic potential in treating Parkinson's disease.
    Lee IJ; Chao CY; Yang YC; Cheng JJ; Huang CL; Chiou CT; Huang HT; Kuo YH; Huang NK
    Biomed Pharmacother; 2021 Feb; 134():111170. PubMed ID: 33383311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Counteracting PINK/Parkin Deficiency in the Activation of Mitophagy: A Potential Therapeutic Intervention for Parkinson's Disease.
    Nardin A; Schrepfer E; Ziviani E
    Curr Neuropharmacol; 2016; 14(3):250-9. PubMed ID: 26517048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PINK1 import regulation at a crossroad of mitochondrial fate: the molecular mechanisms of PINK1 import.
    Sekine S
    J Biochem; 2020 Mar; 167(3):217-224. PubMed ID: 31504668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PINK1/PARKIN signalling in neurodegeneration and neuroinflammation.
    Quinn PMJ; Moreira PI; Ambrósio AF; Alves CH
    Acta Neuropathol Commun; 2020 Nov; 8(1):189. PubMed ID: 33168089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multitasking guardian of mitochondrial quality: Parkin function and Parkinson's disease.
    Kamienieva I; Duszyński J; Szczepanowska J
    Transl Neurodegener; 2021 Jan; 10(1):5. PubMed ID: 33468256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The PINK1/Parkin-mediated mitophagy is compromised by PD-associated mutations.
    Geisler S; Holmström KM; Treis A; Skujat D; Weber SS; Fiesel FC; Kahle PJ; Springer W
    Autophagy; 2010 Oct; 6(7):871-8. PubMed ID: 20798600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.